Key statistics
On Friday, HUTCHMED (China) Ltd (13:HKG) closed at 24.95, 35.89% above the 52 week low of 18.36 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.20 |
---|---|
High | 25.60 |
Low | 24.35 |
Bid | 24.90 |
Offer | 24.95 |
Previous close | 25.20 |
Average volume | 7.45m |
---|---|
Shares outstanding | 872.11m |
Free float | 501.29m |
P/E (TTM) | 74.26 |
Market cap | 21.98bn HKD |
EPS (TTM) | 0.3394 HKD |
Data delayed at least 15 minutes, as of Jul 04 2025 09:08 BST.
More ▼
- HUTCHMED to Announce 2025 Half-Year Financial Results
- Update on Joint Corporate Brokers in London
- Blocklisting Six Monthly Return
- China Approval based on Phase III SACHI Trial
- Total Voting Rights
- HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy
- Grant of Share Options and Awards under LTIP
- HUTCHMED and Innovent Announce NDA Acceptance
- HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
- HUTCHMED Highlights SACHI Phase III Data at ASCO
More ▼